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ABSTRACT 
There being no published data on the seroprevalence of toxoplasmosis in 
the AE, a base -l ine study was canied out on a randomly selected population 
of healthy adults drawn from subjects presenting themselves for a health 
certifi cate at the Department of Preventive Medicine, Al All, or presenting for 
blood donation at the two main hospitals in Al Ain, the Tawam Hospital and 
A l  All H ospital. Commercial ly available VIDAS IgG and IgM kits were used 
to test for seropositivity. A validated questionnaire was used to record personal 
data and blood was drawn from each donor after informed consent. All raw 
data and test results were fed into a computer for a statistical analysis of 
results. 
The overall IgG seropositivity rate was 33 . 6% and the IgM 
seropositivity rate 2 . 7  %, the former on a sample size of 94 1 and the latter on a 
small er sample of 75 owing to l imitation of research funds. 
o s ignificant difference of IgG seropositivity was found between 
samples drawn from Preventive Medicine department and two Blood Banks or 
between the sexes, and although rural dwellers showed lower seropositivity 
(25%) compared to urban dwellers (35 . 1 %), the difference was not significant. 
IgG seropositivity increased with every successive decade of life with 1 9% 
for <20 years old to 42.2% for >50 year old. 
Statistically significant association was found between IgG 
seropositi ity and both nationality groups ( Higher amongst the Jordanians, 
Palestin i ans, Lebanese and Syrians at 56 .4% and lowest amongst Far East 
Asians at 2 1 . 9%) and occupation (surprisingly highest amongst professional 
groups at 48 .3% and lowest amongst farm labourers at 22 .4%) . 
These [mdings are c learly related to the different environmental and 
behavioural factors such as different culinruy habits and vruying lisk factors 
associated with occupation. 
An impOltant fmding was the seropositivity of IgM antibodies against 
Toxoplasma gondii amongst blood donors. Even at the low rate of 2 . 7% a 
transmission risk has been identified. 
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Seroprevalance of Toxoplasmosis 
Amongst 
Healthy Adults in the Al Ain Area 
A IMS 
To establish base-line data on the seroprevalence of toxoplasmosis and 
assess some of the associated ri sk factors in the Al Ain area. 
OBJECTIVES 
1 .  Use of a simple questionnaire to obtain basic epidemiological data from 
two healthy adult sub-populations: 
( a) of persons presenting for normal health screening 
(b) of blood donors, in the Al Ain area. 
2 .  Obtain blood samples and prepare sera from consenting participants. 
3 .  Use the Enzyme Linked Fluorescent Assay (ELFA) for specific anti­
Toxoplasma IgG, to measure prevalence rates; then to assess to any 
correlation between seropositivity and such variables as age, sex, 
domicile, nationality and occupation of each population sub groups. 
4. Use specific anti-Toxoplasma IgM in human serum which is IgG 
positive, with ELF A technique (Enzyme Linked Fluorescent Assay) to 
assess transmission risk amongst potential and actual blood donors . 
5 .  Assess inherent and environmental risk factors that may be associated 
with toxoplasmosis .  
CHAPTER I 
INTRODUCTION 
I .  INTRODUCTI ON 
1 
Toxoplasmosis is  a zoonotic infection caused by an intracellular 
protozoan parasite Toxoplasma gondii. Nicolle and Manceaux ( 1 908) first 
discovered it in a colony of North African rodents, the 'gondii '  (Ctenodactylus 
gondii) kept at the Institute Pasteur in Tunis and named it Leishmania gondii. 
The fol lowing year (Nicolle and Manceaux, 1 909), they renamed it Toxoplasma 
gondzi, derived from the Greek "toxon", an arc or bow, for the shape of the 
orgamsm. 
There are a number of reviews of the hiStOlY of Toxoplasma and 
toxoplasmosis which have contributed to our understanding of the organism 
and its many fOlms of di sease transmission and presentation (Garnham, 1 97 1 ;  
Frenkel, 1 973 ; Jacobs, 1 973 ; Jackson and Hutchinson, 1 989). 
1.1 mSTORICAL 
Soon after the description of the organism by Nicolle and Manceaux, 
Mello ( 1 9 1 0) described the disease in domestic animals. The human disease 
with eye involvement was fIrst recognized by Janku in 1 923 and the congenital 
i nfection in human neonates confrrmed by Wolf et a1., in 1 939 .  Sabin ( 1 94 1 )  
first described the tetrad of symptoms: choroidoretinitis, cerebral calcifIcation, 
hydrocephalus and mental subnOlmal ity .  The recognition of acquired 
toxoplasmosis, or glandular form of the di sease in adults, came in 1 952 
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(Siim, 1 952) and two years later the suggestion was that undercooked meat 
might be the source of hum an infections (Weinman and Chandler, 1 954) .  
Desmonts et ai, ( 1 965) provided good epidemiological evidence for this when 
they observed seroconversion in chi ldren fed on raw meats in a TB hospital in 
Paris .  
L ittle was known of the l ife cycle and hence the toxonomic status of the 
organism, despite numerous experimental transmi ssions in animal s. A report 
(Hutchinson, 1 965) on faecal transmission from the cat stimulated a great deal 
of research.  Initial ly, Hutchinson had held that Toxoplasma was transmitted 
only in association with the nematode Toxocara cati,' however further work by 
Hutchinson et al ( 1 969, 1 970, 1 97 1 ), n et af ( 1 970), Sheffield and Melton 
( 1 970), Overdulve ( 1 970), Weiland and Kiihn ( 1 970), Witte and Piekarski 
( 1 970), and Zaman and Col ley ( 1 970) led to the identification of the oocyst as 
the infective stage in cat faeces and the description of the coccidian nature of 
Toxoplasma. 
3 
1.2 C LASSIFICATION 
The following modified scheme of classification is  that adopted by the 
Society of Protozoologists in 1 980 (Schmidt and Roberts 1 989): 
Phylum Apicomplexa 
Class Sporozoea Subclass Coccidia 
Order Eucoccidiida Suborder Eimeriina 
Family Sarcocystidae Subfami ly Toxoplasmatinae 
Genus Toxoplasma Species gondii 
1.3. M ORPHOLOGY AN D L IFE CYCLE 
The defin i tive host of the parasite is  the cat and other feline hosts. 
Sexual reproduction occurs in the intestinal epithelium resulting in the 
formation of oocysts (Figure. 1 ). 
Oocysts are shed in cat faeces for 7-20 days and as many as 1 0  x 1 0  
6 
oocysts may be shed in a single day, thus heavily contaminating the 
environment. In the soil ,  oocysts sporulate in 1 -2 1  days, depending on 
humidity and temperature (22°C optimum) and may remain infective for a year 
in a humid environment. Desiccation and high temperatures destroy the 
oocysts. 
4 
The intermediate hosts are all warm blooded animals including man' 
and infection occurs through ingestion of mature oocysts through direct 
contamination of food, water, hands; and mechanical vectors such as flies and 
cockroaches. 
The ingested oocysts hatch in the intestine releasing the sporozoites 
which invade the intestinal epithelium to multiply intracellularly, disrupting the 
host cells to infect neighbouring cells .  Tachyzoites also enter leukocytes, 
including macrophages in the lymph drainage, and prol iferate rapidly 
disseminating to every organ and tissue in the body (Figure 2). 
Parasite proliferation and host tissue destruction in immunocompetent 
hosts i s  contained by specific antibody production and a cel l-mediated 
immunity .  Not all parasites are eliminated. Surviving organisms now enter a 
dormant stage in the form of intracel lular cysts or pseudocysts composed of a 
mass of cystozoites now called bradyzoites enclosed by a resistant membrane 
(Figures 3 a-d). 
Tissue cysts are found in virtually every organ but the brain, the eye 
and striated muscles are the most common sites of latent infection, probably 
remaining viable for the rest of the l ife of the host. 
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Figure 3b: Transmission electron micrograph of a 
tachyzoite of Toxoplasma gondii. Various subcellular 
organelees are visible in this view. Nucleus (N), rhoptries 
(R), Golgi apparatus (G), conoid (C) x26,OOO 
(Courtesy of Dr T Jones). 
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Figure 3 d : Pseudocyst of Toxoplasma gondii in mouse brain_ x l OOO 
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Presence of these ti ssue cysts in rodents and other meat animals 
(sheep, cattle, pigs chicken, etc) may account for the enteroepithelial cycle in 
the cat and other fel ine hosts which feed on raw meat . (  Jackson and 
Hutchinson, 1 989) 
1.4. TRANS MI SS I ON AND D I SEASE 
Acquired toxoplasmosis in humans thus has two sources of infection : 
ingestion of oocysts and eating undercooked meats of vruious animals with 
tissue cysts of Toxoplasma gondii. Bradyzoites released from the cysts in  the 
intestine quickly gain access to the lymphatics and behave l ike trophozoites, 
proliferating intracel lularly in non-immune hosts; and fonning cysts in various 
ti ssues and organs. 
Toxoplasmosis may also be acquired through blood transfusion and 
organ transpl ant. The disease is usually mi ld with fever and lymphadenopathy, 
resembl ing "glandular fever". Seropositivi ty is indicative of immunity, though 
dormant cysts persist. Disturbance of the host-pru'asite balance in 
irnmunocompromised patients (e.g. AIDS patients and organ transplant 
recipients) may lead to a more serious disseminated and fatal disease. 
Congenital toxoplasmosis is  dependent on the uruque abil ity of 
tachyzoites to cross the placental barrier. Depending on the time of maternal 
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infection during pregnancy, foetal infection may result in abortion, sti llbirth, 
mi ld to severe eNS, eye, heatt damage to infant, or the appat"ently normal chi ld 
developing bl indness later in l ife ( Schmidt and Roberts, 1 989). 
1.5. HOST PARASITE I NTERACTI ONS 
Toxoplasma i s  able to infect cells and tissues of  all organs in the 
body . The usually mild nature of this acquired disease is therefore surprising. 
However there is no evidence of toxin production by the parasite, and its intra­
cellular location partially protects the parasite from the host immune responses. 
Cystozoites presumably prime the immune responses to provide long-term 
immunity .  
Immunity in toxoplasmosis has been reviewed by Frenkel ( 1 973) .  It 
appears that immunity does not eradicate the infection. Tissue cysts with 
viable cystozoites may be recovered from animals  and humans many years after 
the pli mary infection. These tissue cysts, moreover, may persist even though 
antibody l evel s  may decline or disappear. 
Reactivation of chronic latent infection can occur, as seen in AIDS 
patients, leading to formation of new tissue cysts . Thus, depending on the 
immune status of the host reactivation and proliferation of the pat"asites, may 
lead to local pathology, for example retino-choroiditis and blindness or death 
11 
due to dissemination and prol iferation in vital organs such as the brain or the 
heart. ( Schmidt and Roberts, 1989). 
1.6 D IAGNOSIS  
Diagnosis of  toxoplasmosis may be  made by clinical, 
histopathological, or serological methods, or by isolation by direct smear 
preparation, or passage of tissues from suspected infected hosts into cell 
cultures or laboratOlY mice.  
Clinical SlgnS and symptoms are invariably non-specific. 
Demonstration of Toxoplasma either in smears or in tissue sections is  difficult 
because of the l imited amount of biopsy material ;  though tissue cysts in 
autopsy samples are more readily seen. Isolation in cultures or in laboratOlY 
mice is time consuming and although fai lure to demonstrate the presence of the 
organi sms by thi s  method may be suggestive of lack of infection in the 
suspected case, it does not exclude it .  
Serological tests are used both in diagnosis and in surveil lance. The 
test antigen is either whole, unbroken organisms or extracts from lysed 
parasites. Tests using whole organi sms whether l ive or ki l led, detect antibodies 
against parasite membrane antigens. These are the dye test (Sabin-Feldman 
Dye test), the agglutination test, and the immunofluorescent antibody tests. 
Methods using extracts of lysed organisms include the Complement 
Fixation Test (CFT), the Indirect Haemagglutination Test ( IHAT), the Latex 
u 
Agglutination Test (LT), the Enzyme Linked Immuno Sorbent Assay (ELISA) 
and Enzyme Linked Fluorescent Assay (ELF A). Antigenic extracts, being a 
mixture of many membrane and cytoplasmic antigens, have to be standardized 
in order to interpret test results. For this reason, the tests vary in their 
specificity and sensitivity .  
Although the Sabin Feldman Dye Test sti l l  remams a diagnostic 
standard, technological advancements in automation and sensitivity of detection 
of enzyme reaction products have made ELISA a test of choice for both 
individual patient diagnosis and mass population surveys. A number of 
commercial ELISA systems offer kits that measure specific anti -IgG and anti­
IgM antibodies in test sera. 
Specific anti-Toxoplasma IgM and IgG antibodies develop as a result 
of infection. IgM antibodies reach their peak within a few weeks of infection 
and then decline to insignificant levels by the fOllith month. A sign of acute 
infection, these antibodies may persist for longer in some patients. IgG 
antibodies take 2-3 months to reach their peak and remain elevated, or may 
persist for several months or years. 
1.7. EPIDEMIOLOGY AND ENVIRONMENTAL RISK FACTORS 
A cat may shed upto 1 0  mil l ion oocysts in a day and in the soil 
oocysts sporulate to become infective in 1 -2 1  days depending on humidity, 
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available oxygen and temperature of 4-37°C, with 22°C being optimal . In a 
humid environment they may remain viable for over one year. They are 
resistant to common disinfectants and only kil led by desiccation or heat. This 
provides a ready explanation for the wide spread seropositivity of herbivorous 
animals like sheep, cattle goats, camels and even chickens, which all provide 
meat for man. That oocysts are the prime cause of toxoplasmosis of man is 
more difficult to establish. There is considerable evidence of direct oocyst 
contamination (Stagno et aI . ,  1 980), fly and cockroach borne oocyst infection 
(Wallace, 1 972), and seroprevalence related to presence or absence of cats 
(Wal lace, 1 98 1 ) . 
Acquisition of infection from tissue cysts in meats first suggested by 
Weinman and Chandler ( 1 954), and Desmonts et al ( 1 965) provided clear 
evidence of importance of undercooked meat as a source of infection in 
children fed on rare meat in a TB hospital in Paris .  Serological surveys of 
meat animals world-wide show mean positive rates of 25% (0-99%) in cattle, 
3 1% (0-96%) in sheep and 29% ( 1 -98%) in pigs (Fayer, 1 98 1 ) . Tissue cysts 
are able  to survive for over 2 months at 4°C but are kil led at +60°C or by 
freezing at -9 to -20°C for 3 -4 hours. It is therefore unlikely that well-cooked 
meat is a source of infection. 
The practice of eating undercooked or raw meat is now a wel l  
established risk factor and there is also evidence of transmission through 
14 
ingestion of unpasteurised goats milk (Rieman et aI ., 1 975; Sacks et aI., 1 982). 
The local practice of drinking raw camel milk may be another risk factor. 
Other risk factors may include degree of association with different animals 
(veterinarians farm workers, slaughter-house workers etc). 
Since Toxoplasma may be found in body tissues or fluids, 
transmission through blood transfusion, bone-manow or organ transplant, 
remains a possibility, even though the donor may be asymptomatic .  Recipients 
of blood or grafts who are under chemotherapy are at particular ri sk of 
developing serious disease. 
Seroprevalence amongst selected groups is summarised in Table I 
Population seroprevalence in different geographical areas i s  subject to 
variations in c limate, sanitary conditions, food habits and presence of cats. 
These are summarised in Table ll. 
There is only one study about Toxoplasma seroprevalence among 
pregnant women in the U.A.E .  (Dhaiban , 1 994). She sampled 400 pregnant 
women and found the IgG positive rate of 29.75% . 
Table I :  Prevalence of human toxoplasmosis in varioll group 
based on serological evidence 
Group 








Isolated island populations: 
With cats 
Without cats 



















































NB: Comparison between results is complicated because of different tests 
used to determine prevalences. In addition, prevalences in control groups 
or the rest of the population were not usually reported for comparison. 
(Adapted from Table 3: Jackson and Hutchinson, 1989) 
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(Adapted from Table 7.1: Couvreur and Desmonts, J 988) 
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CHAPTER II 
MATERIALS AND METHODS 
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IT MA TERIALS AND ME THODS 
2. 1. GEOGRAPHY AND DEMOGRAPHY 
The United Arab Emirates lies on the Arabian Gulf with a coast line of 
about 650 km . It covers an area about 77,000 Jan square, most of which is flat 
desert except for the eastern side of the Peninsula, which is mountainous .  It 
has hot, humid summers and the annual rainfall is less than 1 0  cm. which 
occurs during the winter when the temperature is milder. Sand storms blow in 
the spring from the North and the N orth-West. 
U AE is a federation of seven emirates stretching from the borders of 
Qatar and Saudi Arabia to the Musandam peninsula, just south of the strait of 
Hormuz. .  The l argest of  which is Abu Dhabi, consisting of  87% of  the total 
area, while Ajman is the smallest with 259 km square, or 0 . 33% of the total 
area. Before the discovery of oil in 1 958,  the economy of the country was 
limited primarily to oasis agriculture, fishing, pearling and trade with 
neighbouring countries. Oil now represents 95% of total expOIts and 70% of 
the GDP.  
The population of  the UAE was estimated to  be  approximately 
2,0 1 1 ,400 in 1 992 according to the estimate of the Ministry of Planning. The 
economic and social development witnessed by the UAE over the past two 
18 
decades has l ed to significant demographic changes, mainly characterized by 
declining mortality, changing age structure and increasing ferti l ity in the 
indigenous population. 
A significant charactelistic is  male :female ratio which stands currently at 2 .2: 1 .  
Of the population 1 5  years and over 75% are males (Bener et al 1 994), a l arge 
proportion being single male expatriates which affects the male :female 
population ratio. In addition, the UAE has become highly urbanized with more 
than 70% of the population l iving either in cities or in semi-urban townships . .  
Only 3 2% are below 1 5  years of age due to the population pyramid caused by 
the expatriates, particularly males, who mainly fal l  into the age group of 1 5-44 
years (Bener et a l . ,  1 994) .  
2.2. STUD Y  A REA A N D  POPULATION: 
AI Ain City is  situated in the eastern part of Abu Dhabi Emirate near the 
Omani  border. AI Ain is considered the "Garden City" and "Cultural capital" 
of the UAE. In AI Ain, there is an abundance of natural splmgs and fertile 
land. Long before the oil age, the dates and palm trees were one of the basic 
sources of income, at the same time providing food and shelter. The city and 
its surrounding area has a population of about 250,000 and again most of this  
number are expatriates, reflecting the national demographic make-up.  
The study was designed to be in AI Ain Medical District, where the 
department of Preventive Medicine screens all impOlted manpower coming to 
19 
work in Al Ain to ensure they are free of infectious diseases. Though these 
expatri ates belong to different nationalities the majority are from Arabic 
countries, India, Pakistan, Bangladesh, SIi Lanka and the Phil l ipines. 
2 .3. SAM PL ING DESIGN 
A prospective study was carried out during the period between J anuaty 
1 994 to May 1 995 . All subjects were randomly selected from Al Ain and 
Tawam Hospitals which are MiniStIy of Health administered teaching 
hospitals .  As these are the main hospitals in a city catering to a population of 
around 250,000, patients would be representative of the Al Ain population. 
The two hospitals were included in the study also to ensure that al l blood 
donors presenting at both teaching hospitals during a period of one year were 
included. 
The methods used included a simple questionnaire (Fig 4) following the 
multi-stage sampling technique used to select subjects . Stratification allowed 
both urban and rural areas to be proportionally represented. The sample size 
was obtained by assuming that the prevalence rate would be at"ound 30%, 
simil ar to neighbouring Gulf countIies of Bahrain (Yousif et aI . ,  1 99 1 )  and 
Saudi Arabi a  (Abbas et aI. ,  1 986). Therefore, on computing for 99% 
confidence 
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limits and with 5% error bound it yielded the required sample size of 1 200. 
The questionnaire was completed by nurses with the help of a senior medical 
officer and under the supervision of the investigator. The questionnaires and 
administration team were the same in urban and lUral areas. Urban areas were 
those areas situated within the periphelY of the city of Al Ain. Rural areas 
were defined as those vil lages located immediately outside the AI-Ain city 
l imits .  
Prior to the commencement of this study, the repeatabil ity of the 
questionnaire was determined and the same questionnaire a second time, five 
weeks later was administered. No alteration was made to the questionnaire 
prior to its use in the main study sample .  The assessment of repeatabi l ity of the 
questionnaire was performed through the use of Kappa test. 
2.3.1. Sampl ing 
From June 1 993 to the end of March 1 995, 1 200 samples were collected 
randomly from healthy adults who came for health checks or to donate 
blood. A qualified techn ician drew 5-7 ml blood by venepuncture into a 
selUill separator bottle (vacutainer) .  After clot formation in a plain tube, 
serum was separated by centrifugation, dispensed into vials and stored in 
a deep freezer at -30°C unti l  used. The time from collecting the sample 
to storing the seIUm was not more than 48 hours. 
Personal data for each individual was recorded on the questionnaire. 
Collections were made at the fol lowing sites: 
1 .  Preventive Medicine Department, AI Ain 
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2 .  B lood Bank Departments in  both the AI Ain and the Tawam 
Hospitals  
Each donor was invited to  give blood for this survey after the purpose of 
the study was explained. 
All samples were numbered serial ly according to the date of col lection. 
2.3.2. Serologica l Tests. 
Com ercial ly available test kits used were : 
(a) VIDAS toxo IgG (TXG) 
(b) VIDAS toxo IgM(TXM) 
This is an enzyme immunoassay system for the determination of anti 
Toxoplasma IgG and-IgM in human semm using ELFA technique (Enzyme 
Linked F luorescent Assay) supplied by Biomeriux - France. 
2.3.3. Princ ip le  
The vidas toxo IgG/IgM is an automated assay system which enables 
anti Toxoplasma IgG and-IgM. in human selUID to be quantitatively measured. 
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The assay principle combines the enzyme immunoassay method with a 
final fluorescence detection system. The disposable solid phase receptacle 
serves both as a solid phase and pipetting device during the assay. 
2.3.4. Procedure: 
For each test run, computer based VIDAS System was standardized 
according to a set procedure . 
1 .  Programming the machine. 
Because the machine can run different tests, we have to choose the 
test we require, i . e .  TXG or TXM 
2.  Cal ibration of the machine. 
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The machine should be calibrated for each kind of test by entering 
the cal ibration card from the kit and to read it .  The machine should 
be calibrated every 1 4  days. 
3 .  Work l ist creation 
To create a work l i st regarding to the number of tests for either TXG 
or TXM 
4 .  Running Control and Standards 
Positive control  1 and negative control 2 and system standards 1 and 
standard 2 were lUn using 1 001-1 1 amounts . 
5. Loading of samples SPR 
1 001-11 of samples were loaded with cal ibration and control on to the 
strips and the work l ist fol lowed. The detai led methodology is 
described in the suppliers instruction (Fig 5 and Fig 6). 
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Data computation and A nalysis of the results 1IIa based on the follo·wing 1 alue 
Titer (iulml) Interpretation 
<8 
from 8 to 1 0  




In the running of the samples the following precautions were followed 
to avoid by contamination or introduction of any variation in the results .  
1 .  To avoid mixing of reagents from different lots 
2. All reagents were brought to room temperature at least 30 minutes 
before using. 
3 .  T o  handle the strips and samples carefully to treat them as 
potential infectious. 
4. Using disposable latex gloves in handling samples. 
5 .  Shaking all reagents well t o  obtain a better result reproducibility . 
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VI DAS TOXO I g G  ( TXG) 
E zy m e  Immunoassay for  t h e  det e rmtnatlon 
( E nzy me Ltnked Fluorescent  Assay) 
For In vitro dIagnostic use 
of antl- Toxoo lasma IgG ,n  human serum uSing the E L FA technique 
P R I N C I P L E  
T h e  VIDAS TOXO IgG IS an automated assay t o r  h e  
VIDAS system, wnlc h  e n ables ant i-Toxoplasma tgG In 
'1Uman s e r u m  to b e  quantrt atlvelv measured_ The assay 
pnnclole c ombines t h e  enzyme Immunoassay method 
with a ftnal f luorescent detection t E LFA) 
REAGENTS 
Store at  2 -8°C 00 not f reeze the reagents. 
�he expirat io n  date I S  tndlcated on the kit label lng_ 
Kit composit ion (50 tests ) . 
All  reaction steps are performed by he VIDAS 
nstrume nt. The disposable Solid P h as e  R eceptacle 
serves both as a sol ide phase and plpettlng deVice 
dUring the assay. Reagents for t h e  assay are all 
contained In the sealed R eagent Strips. 
1 60 XG stnos Ready-to-use. 
I 
I 
50 TXG S P R s  
2 x 30  
Reaoy-to-use. 
SPRs coated with memorane and cytoplasmiC Toxooiasma ant igen 
Each SPR IS clearlY markea. On ly remove t h e  reau lred numoer of S P Rs 
Make sure the ooucn IS well closea after ooentng. 
I Posit ive iXG control'  x 2 ml ( l iqUid)  Human serum containing ant l - Toxoplasma I gG + p rote in stabi l izer + 0. 1 0/0 of soalum azide. i ter  In IU/ml . range giv e n  on v i al label. 
egatlve TXG con t ro l '  
l x 3 ml ( l ioula) 
I TXG c a librator ' 
1 x 1 ml ( l ioUlo ) 
H u man s e r u m  n e gative tor  ant l - Toxoolasma IgG + prote tn  staoll izer 
• O.  1 o� of SOdiu m aZlae. 
I, Human s e rum c ont ain ing ant l - T oxoolasma IgG a n a  c a l i b rated aga inst t h e  standaro + o roteln stabil izer + 0 1 o� 01 soolu m  aZloe. I Titer In I Ulml given on v ia l label.  
De s c T l o t l o n  of the TXG Reagent S t r I p  
.ve i ls 
J - 5 - , - 8  
Reagents 
I Samole well  
I Serum o l lue n t . - ;:; I S  butter (50 mmov l l  ph 7 4 � o ro t e t n  a na che mical sl abll izers � a o� of sodium aZide ( 600 ul )  
P r e -wasn tn g  outle r ' T R  IS 1 50 mmolll) p H  7 4 + o rotetn a n d  c h e mical stabil izers 
• 0 o� of soolum aZide 1 600 u l) 
I Nashlna b uner . iR IS  (50 mmoll l )  pH 7.4  + oroteln a n a  chemical stabi l izers - 0 1 0/, of SOdium aZide (600 u l )  
:: o n l u a a t e  Alkal ine onosonatase labelled monoc lon al  a n l l - h u m a n  I g G  ant loooies 
' i'louse ) 
- J ')f. of sODIum aZloe ( .l O a  u l ) 
E,-.,o[V well 
C u-/ene wil n s uos t rate J '"T1 e t h v l - u moell l feryl - o n o s o n a t e  
- "" '5 oroauct nas oeen IPsteQ ana �mown I e)  b e  nenalr\ll! lor HBs sunace anl)()en and antOO<lIes t o  H I V  a na He" However 5'nce n o  p,(15l1no lesl ca n  
t"\'altv Quaranlee Inp" aose nce ' '' rJ  orOOUCI must o e  I f � a t ea  a s  OOlanllBltv InfectIOus ana IH\na�d w lt n  tAJ re r-'Jnnprmore n Q  Known mf'tnOf] ca n  1')110, 
f"IrrC)lele assurance I n a l  thiS numan 01000 oroouct do es nOI (Qnlaln ::\nv InlpC1IQU5 a�nl 
': .Jutlon P rO O ue l  Of human onqln for I n  v l lro Olsqnosllc use onlV not InlanoEt(] tor thefa oe l11lC U'88 
- e est c: e nt ' ! lc3t  o n  o t  n u rr oer 3f1d e XO l ral ion a t e  3re ar ''' I '! a  on ' n e  SJ r'O o a f  c e o e  laoel  
- ;" e  t est -: e n  I l lcal i o n .  o t  n u mo e f  c21 10fal lon 0 3 r 3 1T' ,! ! ,! rs a n a  C 3 lio ra or t i e r a r e  " o t n  c e a r lv Indlcateo n I � e  " 5  
:; eCI : IC3\  o n s  s r. e e t  a n a  Of'n ed en ' h e  o a f  ccoe a D e l  
Figure 5: Protocols for JgG determinat ion 
M a t e r i a l s  requi red b u t  n o t  provided 
Plpene with disposable t iP calibrated to disoense 
1 00 �I  
W a r n i n g s  and p recaut i o n s  
1 00 not mix r e a g e n t s  f r o m  dif ferent lots. 
2. Bring reagents  t o  room temperature at least 
30 minutes b efore Inserting them Into VIOAS. 
3 .  I t  IS recommended t o  handle t h e  c alibrator, controls 
and h u m a n  s a mples carefu lly. while observing rou t ine 
laboratory procedures.  T h ey should be treated as 
being P?t e fJ!lally infectlold.§., 
4 Th e Indicator  on t h e  deSiccant In the S P R  storage 
pouc h s h ou l d  b e  b l u e .  1 1  t h e  Indicator has turned pink. 
do not u s e  t h e  remain ing S P Rs I n  t h at pouch. 
5 Mix  cal ibrator. cont rols, s a mples well with a vortex to 
obtain a better  resul t  reproducibi l i ty. 
6 Use powderless,  disposable latex gloves. 
S A M P L E S  
Non- hemolyzed.  u ncontaminated sera or plasmas 
( E DT A. h ep a r i n ,  c i trate ).  T h ey can be stored lor f ive 
days at 2 - 8 °C but must t h e n  be frozen at -20°C. Freeze 
once o n ly.  
H e a t  Inact ivated ( 5 6°C for  30 minutes)  sera may be used 
with V I D A S  Toxo IgG. 
P R OC E D U R E  
E n t e r  o at l e n t  and assay data o n  t h e  V I O AS t e rmin al  to 
create a W o r k  List (see V I O AS User s Manual) .  T h e  
ass av code for  V I D A S  TXG I S  TXG. 
2 M I X  s a m p l e s .  cal ibrator ,  and/or cont rols wit h a vortex. 
3 Plp elle 1 0 0  � I  of  sample. c alibrator andlor cont rols Into 
t h e  striO s f irst sample wel l ,  If t h iS has been directed In 
he Work LIS t .  
Note : A f t e r  r e c e l o t  of a new l o t  01 reagents a n d  every 
1 4  days, c al i b ra t e  uSing the TXG cal ibrator assayed I n  
dupl icate ( s e e  M a n u al .  C hapter on 'Calibratlon 
M e n u ') .  
.l Place the TXG SPR and TXG Reagent Stnp Into the 
POSit ions I n dicated by t h e  V I O AS Work LISt.  
5 Follow p r oc e d u re as directed In the VIDAS User s 
'vIa n u a l .  T h e  assay will be completed In approXimately 
40 minutes.  
Q U A L I T Y  C O N T R O L  
P eriodical ly c h e c k  t h e  re s u lts'  val idity uSing t h e  negative 
and oosltlve c o n t rols.  
The e x pe c t e d  p o s it i ve c o n t r o l  value wil l  be Included I n  
t h e  r a n g e  g iv e n  o n  t h e  v i a l  l a b e l  
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RESU LTS 
When the assay IS c ompleted, t h e  results are analyzed 
automatical ly and t h e  ant i-loxoplasma IgG sample 
concentrations are calculated by V I DAS.  The result s  are 
expressed in I U/ml, In relation to a calib rat ion curve 
stored I n  V I DAS's memory. 
T h resh olds and I nt er p retation of results 
Titer : I U/ml In terpretat ion 
< 8  Negative 
from 8 to 1 0  EqUivocal 
� 1 0  Positive 
EqUivocal samples ( t i ters between 8 and 1 0  IU/ml) 
should be retested. I f  t h e  I n t e rpretat ion remains 
equivocal, then a new sample must be col lected. 
Samples contain ing ant lt oxoplasma IgG conc entrations 
above 300 IUlml can be diluted 1 : 4 In the n egative TXG 
control.  Mult iply the result  by the di lut ion f actor t o  obtain 
t h e  s amples' t iter.  
P E R FO R M A N C E S  
Accuracy 
The p resence 01 IgG antibody to T. gondll was 
determined uSing another  commerC ially av ailable E I A. All 
specimens which had discrepa n t  results were tested 
uSing the Dye - Test and the h emaggl ut inat ion method. 
642 sera were tested.  
The sera found t o  be equivocal With VIDAS Taxa IgG 
have not been used to calculate the p e rformances. 
Specificity 
Of t h e  3 3 1  specimens found to be negativ e ,  330 were 
n egative by t h e  V I D A S  Toxo IgG assay , corresponding 
to a speCif iCity of 99. 7 0/0 (99 % uSing the ot h e r  E I A  
assay). 
Sensitivity 
Of t h e  305 specimens lound t o  be pOSit iv e ,  300 were 
posit iv e  by VIDAS Taxa IgG assay , corresponding to a 
sensi t iv i ty of 98 . 4  % ( 9 1 . 8 % uSing t h e  o t h e r  E I A  assay) 
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W it h i n - r u n  r e p r o d u c i b i l i t y  of VIDAS TaXa IgG Betwei!n-run reprodu c i b i l ity of V I D A S  TaXa IgG 
Nurrber Average Standard WHt1ln· Nurrber Average Standard Between· 
01 assays deviation run 01 assays deviation run 
CV "{, CV '% 
Serum 1 Signal :30 1 373 43 3. 1 2 Serum 1 Signal 10 1 403 34 2.43 
IUlml 30 25 I 4 52 IU/ml 1 0  2 7  1 4 34  
Serum 2 Signal 30 2238 53 2 8 1 Serum 2 Signal 10 2252 8 1  3.52 
IU/ml 30 55 3 4 85 IU/ml 1 0 55 3 5.59 
Serum 3 Signal 30 4 1 74 88 2 . 1 1 Serum 3 Signal 1 0  4 1 57 86 2.06 
IUlml 30 240 1 9  7.72 IU/ml 1 0 236 20 8.65 
PosJIlve Signal 1 0 1 773 53 2.98 
Conlrol IU/ml 10 38 1 3.86 
Complete I nformation , specif ications and references can be found In the VIDAS Package Insert Compendium. 
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V I DAS TOXO 1 9M (TXM) For In vitro diagnostic use 
Enzyme Immunoassay for the detection of anti-Toxoplasma IgM In human serum uSing the ELFA technique (Enzyme 
Linked Fluorescent Assay) 
P R INCIPLE 
The VIDAS TOXO IgM is an automated assay for the 
VIDAS syste m. whICh enables anti-Toxoplasma IgM in 
human serum to be detected. The assay principle 
combines the enzyme immunoassay method With a final 
fluorescent detection (ELFA). After IgM serum 
Immunocapture. the anti-toxoplasma IgM are specifically 
detected With alkaline phosphatase labelled Immune 
complex. 
All reacllOn steps are performed by the VIDAS 
instrument. The disposable Solid Phase Receptacle 
serves both as a solid phase and plpettlng device during 
the assay. Reagents for the assay are all contained In 
the sealed reagent stnps. 
REAGENTS 
Store at 2 -S·C. Do not freeze the reagents. 
The e X�)lfatlon date IS Indicated on the kit labeling. 
Kit composit i o n  (60 tests) : 
60 TXM stripS Ready·to-use. 
60 TXM S P R s  Ready-to-use. 
2 x 30 SPAs sens lllzed wilh anti-human fl chain antibodies (goat) pUrified by affinily 
chromatography. Each SPR is clearly marked. 
Only remove the required number of SP As. 
Make sure the pouch is well closed after opening. 
Posit ive TXM control Human serum· containing antl-Toxoolasma IgM + prote in  stabil izer 
1 x 2 ml (liqUid) + 1 gil of sodium azide. 
Index : range in dicated on vial label.  
Negal iveTXM control H u man serum· negative for anti-Toxoplasma IgM + prote in stab i lizer 
1 x 2 m l  ( l iqUid) + 1 gil of sodium azide. 
TXM standard - Human serum· containing anti' Toxoplasma IgM + prote in stabilizer 
1 x 1 ml (liqUid) + 1 gil of sodium azide. 
Description of the TXM Reagent Strip 
We l ls Reagents 
1 Sarnole well 
2 Serum diluent : T R I S  buffe r ( SO  mmolil) pH 7 4 + p rotein and chemical stabilizers 
+ 1 gil of sodium azide (300 u l) 
3 Pre ·washlng buffer : T R IS (50 mmoVl) pH 7 4 + protein and chemical stabilizers 
+ 1 gl1 of sodium aZide (600 ul)  
4 · 5 · 7 · 8  Washing buHer  : TRJS (50 mmolll) pH 7 4 + protein and chemical stabilizers 
+ 1 gil of sodium aZide (600 un 
6 Con Jugat e : alkaline phosphatase labelled Immune complex ( toxoplasma 
antigen · mouse monoclonal anti P·30 ant ibodies ) + 1 gil  of  sodium aZide 
+ 0.02 0'" Gentamicin ( 400 ul)  
9 Empty well 
1 0  C uvene with substrate ' 4 methyl·umoeil i feryl .phosphate 
+ 1 g/I of  sodium aZide (300 u l )  
This product n a s  Deen leS/ed and snown 10 be neqallve lor H e s  sUn"C8 anllgen ana anllbooles 10 HIV a n d  H G V  However Since n o  ellS/lng lesl melMd 
can totally Quaranlee their absence Ihts product muSI be lrealeO as polenllaUy InleCIIQUS Therelore usual salely procedures should be observed when 
h andling 
C aution : Product of human eng In tor In vl1ro dlagnosllc use only. not Inl .nded tor Iheraoeutlc use 
The test Identrflcalion. lot number. and explfat lon date are orlnted on the sl rlp bar code tabel  
The test  Ide nl if lcal io n . lot  number and cailbralion parameters are both clearly Indicated In t h e  klt's speCifications sheet 
and printed on t h e  bar code. 
Figure 6: Protocols for I gM determinat ion 
Materia ls  requi red but not provi ded 
Pipette with disposable t ip calibrated to dispense 
1 00 IJI .  
Warnings a n d  p recaut i o n s  
1 .  Do n o t  m i X  reagents from different lots. 
2. Bring reagents to room temperature at least 
30 minutes b efore Inserting them into VIDAS. 
3. This kit contains human bl ood products. No 
known a n a l y s i s  meth od can totally guarantee the 
absence of t ra nsmissible pathogenic agents. It Is 
t heref o r e  recommended t hat these products be 
t reated as potentially Infectious, and handled 
obse rv i n g  t h e  usual satety p recautions. 
4 The indicator on the desiccant in  the SPR storage 
pouch should b e  b lue.  If the indicator has turned pink. 
do not use the remarn i n g  S P Rs in that pouch. 
5. Mix standard .  controls . and samples well with a vortex 
to obtarn better res u lt  reproducibi lity. 
6. Use powderless. disposable latex gloves. 
SAMPLES 
Non-hemolyzed, uncontaminated sera or  plasmas 
( E D T  A,  h eparrn , citrate) .  They can be stored for five 
days at 2-SoC but must then b e  frozen at -20°C . Freeze 
once only. 
Heat In activated ( 5 6°C for 30 min utes) sera may be used 
with VIDAS Toxo IgM.  
P R OC E DU R E  
. Enter p atient and assay data o n  the VIDAS terminal to 
create a Work List (see VIDAS User's Manual). The 
assay code for VIDAS TXM is TXM. 
2.  Mix samples, standa rd, andlor controls with a vortex. 
3. Place 1 00 IJI  of sample , standard andlor controls into 
the strrp's f irst sample well .  if t h is has been directed In 
he Work List. 
Note : Afte r  receipt of a new lot of reagents and 
every 1 4  days,  calibrate using the TXM standard 
assayed in d uplicate (see Manual, Chapter on 
'C alibration M e n u ').  
d Place t h e  T X M  S P R  and TXM Reagent StrtP Into the 
posrt lons rndicated by the V I D AS Work List. 
5. Follow procedure as directed in the VIDAS User's 




Penodlcally check the resu lts' validity using the negative 
and posrtlve cont rols. 
The expected positive control va l ue will be included in 
the range gIV e n  on the vial label.  
RESU LTS 
When the assay is completed. the results are analyzed 
automatically and the Index I (ratio of serum to be 
tested's fluorescent signal to the memonzed standard 
signal) is calculated by VIDAS. 
Thresh olds and In t e rp retat ion of Results 
Index Interpretation 
i < 0 . 5 5  Negative 
0.55 � 1 < 0.65 Equivocal 
i � 0.65 Positive 
Equivocal samples ( indices between 0 . 5 5  and 0.65) 
should be retested.  I f  the interpretation remains 
equivocal, then a new sample must be collected. 
PERFORMANCES 
Accuracy 
Comparison of VIDAS TOXO Ig M method w i t h  ISAGA 
method 




Sensitivrty : 93.5 % 
Specificity : 99. 3 % 





VIDAS TOXO IgM 
Equivocal -
0 5 '  
0 3 
5 1 020 
, for the 5 samples found to be n egative With the VIDAS 
TOXO I g M  and pOSitive With ISAGA. t h ree of them were 
found to contain residual IgM. 
Note : The sera found to b e  equivocal with ISAGA 
andlor With VIDAS TOXO I gM have not been used to 
calcu late the sensitivity. speCificity and agre ement. 
3 1  
W it hi n-ru n  reproducibil ity of VIOAS TaXa I g M  Between-run reproducibi l ity of VIOAS TaXa IgM 
Sera N umber Signal Standard Within- Sera Number Index Standard Between-
of  assays Average deviation ru n of assays Average deviation run 
CV O/O CV O/O 
S l  30 82 1 1 . 04 1 3.4 S4 7 2 .09 0. 1 0  4.8 
S2 30 574 30.04 5 .2  S 5  7 0.76 0.04 5.3 
S3 30 1 443 43.09 3.0 S6 7 0. 1 1 0 .01  8 .2  
Complete mformatlon, s p ecrficatlons and references can be found In the VIDAS Package Insert Compe ndiu m. 
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2.3 . 5 .  Data Ana lysis 
The questionnaires were coded, entered and processed in the Department 
of Community Medicine on the IBM computer of Faculty of Medicine and 
Health Sciences at the UAE University. 
The stati stical package program (SPSS) [Nolllsuis ( 1 992)] was used to 
calculate Chi-square to ascertain the association between two or more 
categorical variables in 2x2 tables instead of Chi-square, in particular when the 
sample size was small .  
The relative ri sk (RR) and their confidence intervals (Cl) were obtained 
by using Mantel Haenszel test Ep 1 5  package . Student's-t (two-tailed) test was 
used to determine the significance of difference between two continuous 
variables .  




m RESU LTS 
A total of 1 200 blood samples were obtained from willing donors. 
Howe er, as the number of kits needed do the tests was limited by the 
availability of research funds only 94 1 of the samples were actually tested .  
These were chosen randoml y  from the two main sources of collection, i .e .  the 
Preventive Medicine Department (49 .9%) and Blood Banks at the Tawam and 
AI-Ain Hospitals (50 . 1%). (Fig 7) 
Table ill summanses the socio-demographic characteristics of the 
population surveyed. Of 94 1 serum samples tested, 3 17 (33 .6%) were found 
positive for anti-Toxoplasma IgG antibodies, 6 1 6  (65 . 5%) samples were 
seronegative and 8 (0. 8%) gave equivocal results (Figure 8) .  
Age was divided into five separate age groups :  less than 20 years 
(4. 5%), 2 1 -3 0  years (27 .4%), 3 1 -40 years (5 1 . 3%), 4 1 -50  years ( 1 3 . 1 %) and 
more than 50 years (3 .7%) (Figure 9). 
Of 94 1 serum samples tested for IgG positivity 857 (9 1 .7%) were males 
and 78(8 . 3%) were females (Figure 1 0) .  
Fig.7: Di stribution of sam ples according to the source in AI Ain .  
Preven tive Medic ine 
49 .9% 
Blood Bank 
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Residence was divided into three separate areas : urban (86%), pen­
ul"ban (6 .6%) and rural (7 . 3%),(Figure 1 1 ) . 
Nationality was divided into eight groups: Mediterranean Arabs 1 49 
( 1 6%), African Arabs 1 1 6 ( 1 2 .4%), South Asian 178 ( 1 9. 1%), Far-East Asian 
32  (3 .4%), West Asian (26 .6%), European (3 .4%) ,Gulf Countries 75 (7 .9%) 
and UAE 1 03 ( 1 0 .9%) (Figure 1 2) .  
Occupation was also categorized into six separate groups :  Professional 
62 (6 .6%), office workers 93 (9 .9%), field workers 1 89 (20 . 1 %), fann workers 
86 (9. 1 %), domestic workers 22 (2. 3%) and skil led workers or daily labourers 
489 (52%) (Figure 1 3) .  
Fig. l l :  Distribution of samples according to residential  status in the 
AI Ain area. 
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Table IV srunmarises the socio-demographic characteristics of the population 
according to the IgG seropositivity to Toxoplasma gondii. As can be seen from 
this table there was no significant differences between Preventive Medicine 
Department and Blood Bank concerning Toxoplasma gondii seropositivity. 
There was a trend of increasing seropositivity with age .  There was a 
significant association between national ity and seropositivity (p<0 . 000 1 )  and 
between occupation and seropositivity (p<0 .03) .  However, there was no 
significant effect of sex or residence on seropositivity. 
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Table I V  -Association of Toxop/a rna I gG seroposit ivity with the socio-demographic 
characteristics of the population surveyed 
POS I T I VE N EGAT I VE 
Number Percentage Number Percentage p-value 
Locat ions :  
Preventive Medicine 1 5 8  33 .9  308  66. 1 
Blood Bank 1 59 34 308 66 NS 
Age i n  Years: 
< 20 years 8 1 9  34 8 1  
2 1 -30  years 82 3 1 . 8  1 76 68 .2  <0.05 
3 1 -40 ears 1 62 3 3 . 8  3 1 7  66.2 
4 1 -50  years 49 4 1 .2 70 5 8 . 8  
> 5 0  years 1 6  45 .7  1 9  54 .3  
Sex : 
Male 285 33 .3  572 66.7 
Female 32 42 . 1  44 57 .9  NS 
Area: 
Urban 28 1 3 5 . 1 520 64 .9  
Peri-urban 1 9  30.6 43 69.4 NS 
Rural 1 7  25 5 1  75 
Nationality: 
Mediterranean Arabs 84 56 .4 65 43 .6 
African Arab 34 29.3 82 70 . 7  
South Asian 67 37 .6  1 1 1  62 .4 
Far-East Asian 7 2 1 .9 25 78 .9  p<O.OOOl 
West Asian 59 23 . 8  1 89 76.2 
European 1 1  34 .4 2 1  65 .6 
Gulf countries 24 3 2  5 1  68 
UAE 3 1  30 . l 72 69.9 
Occupation:  
Professional 29 48 .2  3 1  5 l . 7  
Office workers 40 43.5 52 56.5 
Field workers 63 3 3 .3 1 26 66.7 
Farm labourers 1 9  22 .4 66 77 .6 p<0.03 
Domestic workers 7 3 1 . 8 1 5  68 .2 
Skilled or semi-skilled 1 59 32 .8  326 67 .2  
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Seropositivity results related to the different sample variables are as 
fol lows: 
1 .  Sample sou rces: 
Approximately equal numbers of randomly selected serum samples from 
the Preventive Medicine Department and the Blood Banks were tested for IgG 
seropositivity. The results showed no significant difference between the two 
sample populations (Table V , Fig. 7, Fig. 1 4) .  
2. Sex: 
Of 94 1 serum samples tested for IgG positivity, 857 were males and 76 
were females. The seropositivi ty rate among males was 33 . 3% and 42. 1% in 
females (Table VI, Fig. 1 0, Fig. 1 5) .  Relative risk (RR) and their 95% 
confidence interval (Cl) of toxoplasmosis with sexes are also presented and 
estimates were found for males [RR :  0 .79 ; 95% Cl :  0 .60- 1 .05 , p=0. 1 1 8], and 
females [RR: 1 .27 ; 95% CI :  0 .96- 1 .68 , p=0. 1 l 8] .  However, there was 
statistically no significant differences between males and females concerning 
seropositivity. 
3. Age: 
The age distribution of this population sample according to the 
seropositivity is given in (Table VII  and Fig. 9, Fig. 1 6) .  The sample represents 
a nOlmal distribution of groups ranging from 1 5-60 years old.  More frequent 
IgG seropositivity rates being in the 2 1 -30  years and 3 1 -40 years among the 
five age groups .  A Chi-square test for trends showed a significant progressive 
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rate increase from 1 9% to 45.7% (Table VII). Relative risk (RR) and their 
95% confidence interval (C l) of toxoplasmosis with age groups are also 
presented and estimates were found for each age group. 
4. Domici le :  
The seropositivity distribution of this sample population according to 
domicile is shown in (Table VII I  , Fig. 1 1 , Fig. 1 7). Most of the sample 
population 80 1 (86%) was resident in the city of AI Ain .  Results of 19G 
seropositivity rates amongst inner city (urban) outer city (peri-urban) or 
isolated (rural )  dwellers showed no statistical ly significant differences in their 
rates .  Relative risk (RR) and their 95% confidence interval eCl) of 
toxoplasmosis with domicile are also presented. There was statistical ly no 
significant difference between urban, peri-urban and rural dwellers 
concerning seropositivity . 
5. Nat iona l i ty: 
The sample represented some 22 nationalities. Those were grouped into 
8 geographical areas representing broad socio-cultural sub-groupings (Table IX 
, Fig. 1 2, Fig. 1 8) .  
a. Subgroup I :  Designated as Mediterranean Arabs consisted of 1 49 
subjects or 1 6% of sample population and included Jordanians, Syrians, 
Palestinians, and Lebanese. This sub-group showed the highest 
seropositivity rate of 56.4%. 
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b. Subgroup IT:  Designated as African Arabs consisted of 1 1 6 subjects 
or 28 .2% of sample population, included Egyptian, Moroccan, 
Mauritanian, Sudanese and Somali nationals .  This sub-group showed a 
seropositivity rate of 29.3%. 
c. Subgroup I l l : Designated as South Asians consisted of 178 subjects 
or 1 9 . 1% of sample population and included Indians, Sri-Lankans, and 
B angladeshis .  This sub-group showed the second h ighest seropositivity 
rate of 37 .6%.  
d.  Subgroup VI :  Designated a s  Far East Asians consisted of  32 
subjects or  49 .4% of sample population and included, Fi l ipino and 
Japanese nationals . This sub-group showed a seropositivity rate of 
2 1 . 9%. 
e.  Subgroup V: Designated as West Asians consisted of 248 subjects or 
26 .6% of sample population and included Pakistani and Iranian 
nationals .  The seropositivity rate of this sub-group was 23 . 8%. 
f. Subgroup VI : Designated as Europeans consisted of 32  subjects or 
3 .4% of sample population and included Britons, Americans and 
Canadians. Seropositivity rate in this sub-group was 34.4%. 
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g. Subgroup VI I :  Designated as Peninsula Arabs or Gulf Countries 
consisted of 75 subjects or 8% of sample population and included Saudi, 
Omam,  Yemeni, Bahraini and Kuwaiti nationals. This sub-group 
showed a seropositivity rate of 32%. 
h .  Subgroup V I I I :  Designated as UAB nationals, consisted of 1 03 
subjects or 1 1% of the sample .  All were citizens of United Arab 
Emirates .  This sub-group had the lowest seropositivity rate of 1 8 .2%. 
We then compared UAB nationals with other nationalities with regard to 
toxoplasmosis seropositivity (Table X).  We obtained Relative Risk, 95% 
Confidence Interval and p-value for significance differences between the UAB 
and other nationalities. Statistically significant differences were found between 
seropositivity in UAE nationals and others (Table X). 
6. Occupat ion:  
The seropositivity distribution of this sample population according to 
occupation is shown in (Table XI , Fig. 1 3 ,  Fig. 1 9) .  The sample distribution of 
the various occupations were classified in six categories :  professionals 
(doctors, engineers, teachers), Office workers (secretarial and clerical jobs), 
field workers, farm workers (agricultural workers or workers looking after 
animals) domestic workers (mostly house-maids or servants, or house wives) 
and skil led or semi-ski l led jobs. 
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The results of the IgG seropositivity rates amongst the different 
occupation groups was surprising. The highest was among the professional 
groups (48 . 3%) [RR: 1 .47 ; 95% CI :  1 . 1 1 - 1 .93 , p=0.0 1 5 ]; fol lowed by office 
workers (43 . 5%) [RR: 1 . 32  ; 95% CI :  1 .03- 1 .70 , p=0.042]; field workers 
(33 . 3%) [RR:  0 .98 ; 95% CI :  0.78- 1 . 22 , p=0 .834] .; skilled or semi­
skil led(32 . 8%) [RR: 0 .93 ; 95% CI :  0 .78- 1 . 1 1  , p=0.423]; domestic workers 
(3 1 , 8%) [ RR:  0 .94 . 95% CI :  0 .5 1- l .75 , p=0 . 845] .; and the lowest amongst 
fann labourers (22 .4%) [RR: 0 .64 ; 95% CI :  0 .42-0. 96 , p=O.0 17] . 
IgM seropost ivi ty amongst B lood Donors 
60 of the IgG positive and 1 5  of the IgG negative sera were randomly 
selected and tested for presence of Toxoplasma specific IgM antibodies, using 
the VIDAS IgM Kit. 
Table XII shows the results of test for anti-Toxoplasma IgM antibodies 
amongst a sample of B lood Donors. Two of the 60 tested (3 . 3%) were 
positive, one with a significant titre and the other with a very high titre. The 
overall IgM seropositivity amongst blood donors was 2/75 or 2 .7%. 
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Table V Seroposit iv i ty for toxoplasmosis according to the sample 
source* 
Toxoplasma Toxoplasma Relative risk p value 
Positive Negative & 95% C I  
Variable n=3 1 7  (%) n=6 1 6  (%) 
Locations : 
Preventive Medicine 1 5 8  (33 .9) 308 (66. 1 )  1 . 00 [0 .83- l . 1 9 ]  0 .963 
Blood Banks 1 59 (34) 308 (66) l .00 [0 . 84- l .20] 0 .963 
Total 3 1 7  6 1 6  
*Mantel-Haenszel test was perfonned for significance difference, Relative Risk (RR) and 95 % 
Confidence Interval (Cl) 
5 1  
Table VI Seroposit ivity for toxoplasmosis according to sex distr ibut ions 
Toxoplasma Toxoplasma Relative risk p value 
Positive Negative & 95% CI 
Variable 0=3 1 7  (%) 0=6 1 6  (%) 
Sex : 
Male 285  (33 .3 )  572 (66. 7) 0 . 79 [0 .60- 1 .05 ] 0 . 1 1 8 
Female 32 (42. 14 )  44 (57 .9) 1 .27 [0 .96- 1 . 68]  0 . 1 1 8 
Total 3 1 7  6 1 6  
*Mantel-Haenszel test was perlonned for significance difference, Relative Risk 
(RR) and 95 % Confidence Interval (CI) 
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Table VI I Seroposit ivity for toxoplasmosis according to the age distribution 
Toxoplasma Toxopla ma Relative risk p value 
Positive Negat ive & 95% CI  
Variable n=3 1 7  (%) n=6 1 6  (%) 
Age in  years: 
<20 years 8 ( 1 9) 34 (8 1 )  0 .55 [0 .29- 1 .03 ]  0 .366 
2 1 -30 years 82 (3 1 .  8)  1 76 (68.2) 0 .9 1 [0 .74- 1 . 20) 0 . 382 
3 1 -40 years 1 62 (33 . 8) 3 1 7  (66 .2) 0 .99 [0 .83- 1 . 1 8 ] 0.9 1 7  
4 1 -50  years 49 (4 1 . 2) 70 (58 .8) 1 . 25 [0 .99- l . 5 8 ]  0 . 75 
> 50 years 1 6  (45 . 7) 1 9  (54.3) 1 . 33  [0 .92- l . 94] 0 . 1 62 
Total 3 1 7  6 1 6  
*Mantel-Haenszel test was perfonned for significance difference, Relative Risk (RR) and 95 % 
Confidence Interval (el) 
S3 
Table VI I I  Seroposit ivity for Toxoplasmosis according to the domicile'" 
Toxoplasma Toxoplasma Relative risk p vaJue 
Positive Negat ive & 95% CI 
Variable n=3 1 7  (%) n=6 1 6  (%) 
Living area: 
Urban 28 1 (35 . 1 )  520 (64.9) l . 29 [0 .96- 1 . 73]  0 .079 
Peri-urban 1 9  (30.6) 43 (69 .4) 0 .90 [0 .6 1 - 1 .32]  0 . 566 
Rural 1 7  (25) 5 1  (75) 0 .72 [0 .47- 1 .70] 0 . 1 04 
TotaJ 3 1 7  6 1 6  
*Mantel-Haenszel test \ as performed for significance difference, Relative Risk (RR) and 95 % 
Confidence Interval (Cl) 














Seroposit ivity for toxoplasmosis accord ing to the nat ional i ty 
d istr ibut ions* 
Toxopla ma Toxoplasma Relative risk p value 
Posit ive Negative & 95% CI 
n=3 1 7  (%) n=6 1 6  (%) 
84 (56 .4) 65 (43 .6) 1 . 90 [ 1 . 59-2 .27]  0 .000 1 
34 (29 .3 )  82  (70 .7) 0 .85  [0 .63- 1 . 1 4 ]  0 .257 
67 (37 .6) I I I  (62.4) 1 . 1 4 [0 .92- 1 .4 1 ]  0 .25 1 
7 (2 l .9) 25 (78 . 1 )  0.64 [0 .33- 1 .23 ]  0. 1 40 
59  (23 . 8 )  1 89 (76 .2) 0 .63 [0.50-0 .8 1 ]  0 .000 1 
1 1  (34 .4) 2 1  (65 .6) 1 .0 1  [0 .62- 1 .65 ]  0 .96 1 
24 (32) 5 1  (68) 0 .94 [0.67- 1 . 32 ]  0 . 706 
3 1  ( 1 8 .2) 72 (6. 1 )  0 .87  [0 .64- 1 . 1 9 ]  0 .378 
3 1 7 6 1 6  
*Mantel-Haenszel test was performed for significance difference, Relative Risk 
(RR) and 95 % Confidence Interval (Cl) 
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Table X Compa rison of toxoplasmosis seroposit ivity between UAE and 
other nat iona l i t ies" 
Relat ive Risk 
( RR) 
Nat iona l i t ies : 
UAE - Mediterranean 0.49 
Arabs 
UAE - African Arabs 0 .95 
UAE - South Asian 0 .59 
UAE - Far East Asian 1 .70 
UAE - West Asian 0 .66 
UAE - European 1 . 53  
UAE - Gulf countries 1 . 1 4 
95% 
Confidence 
Interva l (CI) 
[0 .36-0. 67] 
[0 .73- 1 .24 ] 
[0 .44-0 . 80] 
[ 1 .43-2 .02] 
[0.49-0 .88 ]  
[ 1 .25- 1 . 86] 










* Mantel-Haenszel test was performed for significance difference, Relative Risk 
(RR) and 95 % Confidence Interval (Cl) 
S6 
Table  X I  Seropos it iv i ty for toxoplasmosis according t o  the occupat ion 
distr ibut ions* 
Toxoplasma Toxoplasma Relative risk p value 
Positive Negat ive & 95% CI 
Variable n=3 1 7  (%) n=6 1 6  (%)  
Occupation: 
Professional 29 (48 .3 )  3 1  (5 l .  7) 1 .47 [ l . 1 1 - 1 .93 ]  0 .0 1 5  
Office workers 40 (43 .5 )  52  (56 .5 )  1 . 32 [ 1 .03 - 1 . 70] 0 .042 
Field workers 63 (3 3 . 3 )  1 26 (66 .7)  0 .98 [0 .78- 1 .22] 0 .834 
Fann labourers 1 9  (22 .4) 66 (77 .6) 0 .64 [0.42-0 .96] 0.0 1 7  
Domestic workers 7 (3 1 . 8)  1 5  (68 .2) 0 .94 [0 .5 1 - 1 .75 ]  0 .845 
Skilled or semi- 1 59 (32 .8  326 (67.2) 0 .93 [0 .78- 1 . 1 1 ]  0 .423 
skilled 
Total 3 1 7  6 1 6  
*Mantel-Haenszel test was perfonned for significance difference, Relative Risk (RR) and 95 % 
Confidence Interval (Cl) 
Table  X I I  IgM seroposi t iv i ty amongst b lood donors 
IgG+ I gG-
I gM+ 2 o 
I gM- 58  1 5  
Tota l  60  1 5  


















Fig. 1 4: Distribution of positive and negative cases according 
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Fig. I S: Sex distribution in the positive and negative cases 
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F i g. 1 8: D i s tr i ll l 1 t io ll of  Pos i t ive & Nega t ive cases acco a rd i ng to the 
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IV. D I SCUSSION 
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Toxoplasmosis is a wide-spread disease that occurs in most countries. It 
i s  a quite serious infection in both man and animals .  It is a systemic disease 
which may end with grave eNS and ocular complications. Infection to man is 
through different routes, but mainly through contact with domestic animals 
(Stray-Pedersen, 1 992). 
Sero-epidemiologic data on Toxoplasma antibody prevalence is 
important because of its relevance to the strategic approach for preventing 
toxoplasmosis in the United Arab Emirates. There is very little infOlmation 
avai lable on this subject in the UAE and to my knowledge a cross-sectional 
prevalence of toxoplasmosis has not been reported before in the UAE. This 
report is the fIrst research focusing on the immune status to Toxoplasma in 
general UAE population . This study has establ ished the prevalence rate of 
toxoplasmosis for our area. The incidence of acute toxoplasmosis in UAE 
population was defIned as presence of specifIc anti Toxoplasma gondii IgM 
antibodies amongst Toxoplasma specifIc IgG positive samples. This study also 
showed a wide variation of seropositivity to Toxoplasma gondii exists amongst 
the different sections of the UAE population . This could be due to the 
varying back grounds of the different and many national ities residing and 
working in thi s  country. Also, geo-climatic conditions are variable 
65 
and may be a factor in the epidemiology Toxoplasma infection. The overall 
prevalence rate of 33 . 6% is comparable with Saudi Arabia (3 1 .  2%) previously 
reported for the Western Region of Saudi Arabia (Basalamah and Serebour, 
1 98 1 ) . Also nearly 37% of all Saudi women possess IgG protective antibody 
(Abbas et al . ,  1 986). This ranges from a low incidence of 22. 8% in Hofuf to a 
high incidence of 5 1 .2% in Abha. However, the 32 .4% found in Jeddah 
compared with 3 1 .2% previously reported, despite the use of different 
serological techniques. 
The seroprevalence rate of 33 .6% of Toxoplasma infection among the 
UAE population is relatively lower than the overall prevalence of 37.4% 
reported from Saudi Arabia (Abbas et. aI. , 1 986), a neighbouring Arabian Gulf 
country. The immune status of the population for toxoplasmosis and the 
prevalence of the disease among subjects varies greatly from country to 
country. This is apparent even among different population groups of the same 
country as has been reported in Saudi Arabia by various studies, (Basalamah 
and Serebour, 1 98 1 ;  Abbas et al .  1 986). It has been reported that more than 
one third of human beings in most areas of the world are infected with 
toxoplasmosis .  Infection rates ranging from as low as 7% were recorded in 
some countries such as N Olway to as high as 94% in other such as Guatemala 
(Morsy and Michael et al., 1 980) .  
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The overall 3 1 7  subjects (33 . 6%) seropositivity rate for Toxoplasma IgG 
antibodies in our region is similar to those reported in some parts of Western 
European countries such as UK and USA (Remington and Desmonts, 1 990). 
Our results are in agreement with the fmdings of Rifaat et a1 . ( 1 978).  However, 
our results are somewhat higher than those of Shoura et a1 . ( 1 973), who 
reported a low prevalence rate of 2 1  % in Saudi Arabia. (Morsy et a1 . ,  1 977) 
who reported a high percentages among Jordanian (37 .09%). Also, some 
authors reported higher seroprevalence figures of 87% for the French and 75% 
for El Salvadorians( Couvreur and Desmonts, 1 988) .  
Differences in the varymg prevalence rates may be explained by 
different serologic methods used in sampl ing techniques or the period of study. 
Infections occur through tissue cyst consumption in undercooked meat or by 
ingestion of vegetables contaminated with oocyst from cat faeces. Risk factors 
such as the l ife style of the population studied, the prevail ing climatic 
conditions, and cultural and culinary habits may therefore play a significant 
role in epidemiology of Toxoplasma gondii infection. 
With regard to the prevalence rate differences of toxoplasmosis between 
males and females in the UAE population, the present study revealed that there 
was no significant difference between males and females. 
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According to the age groups the highest rates of infection were among 
more than 50 year age group (42.2%) . The lowest percentage of infection was 
found among the age group less than 20 years ( 1 9%). There was a steady 
increase in the prevalence rate with increased age. This fmding is in agreement 
with those of Frenkel and Ruiz ( 1 98 1 ), Barbie et al . ( 1 983), and Romia et al .  
( 1 988) who reported that prevalence rate of infection increases with age . 
Additional ly social l ife and econOffilC factor such as income, 
occupation housing conditions, health behaviours and l ife styles may play a 
role in the infection of the disease. The distribution of our sample population 
according to domici le shows most of the sample population (86%) was resident 
in the c ity of AI-Ain. Results of IgG seropositivity rates amongst inner city 
(urban), outer city (peri-urban) or isolated (rural) dwellers however, showed no 
statistical ly significant differences. 
The present study showed that the percentage of infection with 
toxoplasmosis among expatriates i s  higher than that among the natives (90 .2% 
and 9 . 8% respectively). Such higher percentage of infection among expatriates 
could be attributed to the fact that the families from overseas who are resident 
in the UAE usually prefer the existence of pet animals in their homes. Natives 
prefer to keep animals outside their homes. Moreover, they prefer camels, 
goats, sheep and birds. Such animals do not live in direct contact with natives 
68 
and are bred in special areas reasonably far away from hwnan accommodation. 
Additional ly the cooking methods among foreign families could be another 
contributing factor leading to infection with such parasites .  Also expatriates 
and their famil ies may have contracted the infection in their home countIy 
before arrival in the UAE. 
The results of present study showed considerable differences in the 
seropositivi ty rates amongst the different sub population groups. Within the 
total of positive cases, we calculated the percentage of positivity by nationality 
groups as fol lows: Meditenanean Arab (26. 5%), South Asian (2 1 . 1 %), West 
Asian ( 1 8 . 6%), African Arabs ( 1 0. 7%), UAE (9. 8%), Gulf Countries (7. 6%), 
European (3 .5%) and Far East Asian (2. 2%). However within the population 
groups the highest seropositivity rate was found amongst Mediterranean Arabs 
(56. 4%) and the lowest among far East Asian (2 1 . 9%). Other subgroups l ike 
South Asian (37 .6%), European (34 .4%), Gulf Arabs (32%), UAE Nationals 
(30 . 1 %) and African Arabs (29 .3%) had higher rates than West Asian. 
The present study showed a considerable difference in the rate of 
seropositivity related to different occupations. Results of the IgG seropositivity 
rates amongst the different occupation groups was surprisingly highest among 
the skil led or semi-skil led (50.2%), fol lowed by field workers ( 1 9. 9%), office 
workers ( 1 2 . 6%), professionals (9. 1 %), farm labourer (6%), and domestic 
workers (2 .2%). There were very highly significantly differences between 
professional vs field worker (p<0 .000 1 ), ski l led-semi skil led vs professionals 
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(p<0.000 1 )  ski l led-semi skil led vs farm workers (p<0 .000 1 )  and ski l led-semi 
ski l led vs office workers (p<0. 000 1 ) . Within the occupation groups, however, 
professionals had the highest seropositivi ty rate (48 . 3%) and farm labourers the 
lowest (22 .4%). 
CHAPTER V 
CONCLUSION 
v. CONCLUSI O N  
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An important fmding of this study was the theoretical possibil ity of 
transmission of toxoplasmosis through blood transfusion. Previous reports of 
seroprevalence of toxoplasmosis amongst blood donors have ranged from the 
low 1 . 2-4 .6% (Morakote et al, 1 984) and 7.6-7.8% (Jackson et al, 1 987) to a 
h igh rate of 42% amongst blood donors in Kenya (Griffm and Wil l iams, 1 983) .  
Our own IgG seropositivity rate of 34% amongst blood donors was very close 
to our general healthy adult population rate of 33 .6% suggesting that our 
blood donor sampling was not biased. Also, serum IgG positivity is  regarded 
as an immune state in toxoplasmosis. 
In order to determine the actual risk of transmission it was important to 
assess the IgM seropositivity amongst blood donors. Depending on the titre this 
would reflect either current or acute infection or recent infection. Although 
our sample  size was small (75) because of shortage of research funds, the IgM 
seropositivity rate of 2 . 7% was significant in that one of the two positive 
samples showed a high titre. This suggested a significant risk of transmission of 
toxoplasmosis to susceptible recipients . 
The risk of blood or blood products transfusion is  wel l-known for 
toxoplasmosis (Siegel et al . ,  1 97 1 ;  Roth et al . ,  1 97 1 ), particularly in 
immunocompromised subjects or pregnant women. Toxoplasmosis may take a 
7 1  
fatal course in  the fonner and cause abortion, sti l lbirth or severe congenital 
defects of the baby in the latter case . Our resul ts suggest that the present 




VI. RECOMMEN DATIONS 
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2 .  By establishing a clear risk factor of blood transfusion in transmission of 
toxoplasmoisis, thi s  study opens the doors for an extensive research to obtain 
definitive guidelines in the development of a national policy on blood bank 
screening procedures, particularly for recipients who are immunocompromised or 
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